GILD

Gilead Sciences
D

GILD

93.370
USD
0.80
(0.86%)
Pre Open
Volume
1
EPS
4
Div Yield
3.3
P/E
1,037
Market Cap
116,363,843,068
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    2.750
    (1.57%)
    178.450 USD
    AMGN
    AMGN
    0.51
    (0.19%)
    263.97 USD
    BIIB
    BIIB
    2.740
    (1.87%)
    149.330 USD
    BMY
    BMY
    0.290
    (0.51%)
    57.570 USD
    GSK
    GSK
    0.485
    (1.44%)
    34.080 USD
    JNJ
    JNJ
    0.780
    (0.54%)
    145.230 USD
    MRK
    MRK
    1.210
    (1.23%)
    99.360 USD
    PFE
    PFE
    0.350
    (1.33%)
    26.710 USD
    REGN
    REGN
    12.38
    (1.76%)
    714.98 USD
    More
News

Title: Gilead Sciences

Sector: Healthcare
Industry: Drug Manufacturers - General
Gilead Sciences Inc. is an American biopharmaceutical firm that was founded in 1987 under the name Oligogen by Michael L. Riordan. The company specializes in the research, development and sale of medicines in underdeveloped research areas. To this end, the company engages its research in such areas as the human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under many brand names, including Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Sovaldi and more. The company is headquartered in Foster, California, and its stock is measured on the NASDAQ Biotechnology Index and the S&P 500 Index.